Complications of liver biopsy in liver transplant patients: Increased sepsis associated with choledochojejunostomy

Mark E. Bubak, Michael K. Porayko, Ruud A F Krom, Russell H. Wiesner

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

We investigated the incidence and types of liver biopsy complications in our first 160 consecutive liver transplantations. A significant complication was identified by the need for therapeutic intervention (for example, hospitalization, transfusion, intravenous fluids, chest tube, surgery or antibiotic therapy). A total of 950 percutaneous hepatic allograft biopsies were performed in 136 patients (mean = 6.9 biopsies/graft; range = 1 to 29). A significant complication was reported after 17 (1.8%) liver biopsies in 13 (9.6%) patients. Bleeding complications occurred in 11 patients and serious infection developed in 6 patients, but all patients recovered with appropriate therapy. Of special interest was that five of six patients with infectious complications had undergone Roux-en-Y choledochojejunostomy as part of the transplantation operation. The incidence of infectious complications related to a series of biopsies was significantly greater in patients who underwent choledochojejunostomy (12.5%) than in patients who underwent duct-to-duct biliary anastomosis (1%) (p < 0.01). Furthermore, all septic events in patients who underwent choledochojejunostomy were related to enteric organisms. This investigation reaffirms the safety and low incidence of complications related to percutaneous liver biopsy even in this unique patient population. However, we did identify a subgroup of patients with biliary-enteric anastomoses who appear to be at increased risk of septic complications after liver biopsy. Antibiotic prophylaxis at the time of liver biopsy may be appropriate in this high-risk subgroup to decrease the frequency of infectious complications.

Original languageEnglish (US)
Pages (from-to)1063-1065
Number of pages3
JournalHepatology
Volume14
Issue number6
StatePublished - Dec 1991

Fingerprint

Choledochostomy
Sepsis
Transplants
Biopsy
Liver
Incidence
Chest Tubes
Antibiotic Prophylaxis
Liver Transplantation
Allografts
Hospitalization
Therapeutics

ASJC Scopus subject areas

  • Hepatology

Cite this

Bubak, M. E., Porayko, M. K., Krom, R. A. F., & Wiesner, R. H. (1991). Complications of liver biopsy in liver transplant patients: Increased sepsis associated with choledochojejunostomy. Hepatology, 14(6), 1063-1065.

Complications of liver biopsy in liver transplant patients : Increased sepsis associated with choledochojejunostomy. / Bubak, Mark E.; Porayko, Michael K.; Krom, Ruud A F; Wiesner, Russell H.

In: Hepatology, Vol. 14, No. 6, 12.1991, p. 1063-1065.

Research output: Contribution to journalArticle

Bubak, ME, Porayko, MK, Krom, RAF & Wiesner, RH 1991, 'Complications of liver biopsy in liver transplant patients: Increased sepsis associated with choledochojejunostomy', Hepatology, vol. 14, no. 6, pp. 1063-1065.
Bubak, Mark E. ; Porayko, Michael K. ; Krom, Ruud A F ; Wiesner, Russell H. / Complications of liver biopsy in liver transplant patients : Increased sepsis associated with choledochojejunostomy. In: Hepatology. 1991 ; Vol. 14, No. 6. pp. 1063-1065.
@article{38263526fffb4ef88b6e99ad0ff3ac09,
title = "Complications of liver biopsy in liver transplant patients: Increased sepsis associated with choledochojejunostomy",
abstract = "We investigated the incidence and types of liver biopsy complications in our first 160 consecutive liver transplantations. A significant complication was identified by the need for therapeutic intervention (for example, hospitalization, transfusion, intravenous fluids, chest tube, surgery or antibiotic therapy). A total of 950 percutaneous hepatic allograft biopsies were performed in 136 patients (mean = 6.9 biopsies/graft; range = 1 to 29). A significant complication was reported after 17 (1.8{\%}) liver biopsies in 13 (9.6{\%}) patients. Bleeding complications occurred in 11 patients and serious infection developed in 6 patients, but all patients recovered with appropriate therapy. Of special interest was that five of six patients with infectious complications had undergone Roux-en-Y choledochojejunostomy as part of the transplantation operation. The incidence of infectious complications related to a series of biopsies was significantly greater in patients who underwent choledochojejunostomy (12.5{\%}) than in patients who underwent duct-to-duct biliary anastomosis (1{\%}) (p < 0.01). Furthermore, all septic events in patients who underwent choledochojejunostomy were related to enteric organisms. This investigation reaffirms the safety and low incidence of complications related to percutaneous liver biopsy even in this unique patient population. However, we did identify a subgroup of patients with biliary-enteric anastomoses who appear to be at increased risk of septic complications after liver biopsy. Antibiotic prophylaxis at the time of liver biopsy may be appropriate in this high-risk subgroup to decrease the frequency of infectious complications.",
author = "Bubak, {Mark E.} and Porayko, {Michael K.} and Krom, {Ruud A F} and Wiesner, {Russell H.}",
year = "1991",
month = "12",
language = "English (US)",
volume = "14",
pages = "1063--1065",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Complications of liver biopsy in liver transplant patients

T2 - Increased sepsis associated with choledochojejunostomy

AU - Bubak, Mark E.

AU - Porayko, Michael K.

AU - Krom, Ruud A F

AU - Wiesner, Russell H.

PY - 1991/12

Y1 - 1991/12

N2 - We investigated the incidence and types of liver biopsy complications in our first 160 consecutive liver transplantations. A significant complication was identified by the need for therapeutic intervention (for example, hospitalization, transfusion, intravenous fluids, chest tube, surgery or antibiotic therapy). A total of 950 percutaneous hepatic allograft biopsies were performed in 136 patients (mean = 6.9 biopsies/graft; range = 1 to 29). A significant complication was reported after 17 (1.8%) liver biopsies in 13 (9.6%) patients. Bleeding complications occurred in 11 patients and serious infection developed in 6 patients, but all patients recovered with appropriate therapy. Of special interest was that five of six patients with infectious complications had undergone Roux-en-Y choledochojejunostomy as part of the transplantation operation. The incidence of infectious complications related to a series of biopsies was significantly greater in patients who underwent choledochojejunostomy (12.5%) than in patients who underwent duct-to-duct biliary anastomosis (1%) (p < 0.01). Furthermore, all septic events in patients who underwent choledochojejunostomy were related to enteric organisms. This investigation reaffirms the safety and low incidence of complications related to percutaneous liver biopsy even in this unique patient population. However, we did identify a subgroup of patients with biliary-enteric anastomoses who appear to be at increased risk of septic complications after liver biopsy. Antibiotic prophylaxis at the time of liver biopsy may be appropriate in this high-risk subgroup to decrease the frequency of infectious complications.

AB - We investigated the incidence and types of liver biopsy complications in our first 160 consecutive liver transplantations. A significant complication was identified by the need for therapeutic intervention (for example, hospitalization, transfusion, intravenous fluids, chest tube, surgery or antibiotic therapy). A total of 950 percutaneous hepatic allograft biopsies were performed in 136 patients (mean = 6.9 biopsies/graft; range = 1 to 29). A significant complication was reported after 17 (1.8%) liver biopsies in 13 (9.6%) patients. Bleeding complications occurred in 11 patients and serious infection developed in 6 patients, but all patients recovered with appropriate therapy. Of special interest was that five of six patients with infectious complications had undergone Roux-en-Y choledochojejunostomy as part of the transplantation operation. The incidence of infectious complications related to a series of biopsies was significantly greater in patients who underwent choledochojejunostomy (12.5%) than in patients who underwent duct-to-duct biliary anastomosis (1%) (p < 0.01). Furthermore, all septic events in patients who underwent choledochojejunostomy were related to enteric organisms. This investigation reaffirms the safety and low incidence of complications related to percutaneous liver biopsy even in this unique patient population. However, we did identify a subgroup of patients with biliary-enteric anastomoses who appear to be at increased risk of septic complications after liver biopsy. Antibiotic prophylaxis at the time of liver biopsy may be appropriate in this high-risk subgroup to decrease the frequency of infectious complications.

UR - http://www.scopus.com/inward/record.url?scp=0026347984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026347984&partnerID=8YFLogxK

M3 - Article

C2 - 1959854

AN - SCOPUS:0026347984

VL - 14

SP - 1063

EP - 1065

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 6

ER -